FDA Inspection
LFB USA, Inc.LFB USA, Inc. – FDA Inspection, Apr 8, 2022
Record Details
This FDA Inspection record concerns LFB USA, Inc., with an inspection on April 8, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- LFB USA, Inc.
- Inspection Date
- April 8, 2022
- Product Type
- Biologics
View Company Profile
ID · 32131f58-e830-4004-90ba-bbf5cea1313d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1174664
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of LFB USA, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 22, 2017 | NAI | Center for Veterinary Medicine | Bioresearch Monitoring |
| May 12, 2017 | Not classified | New England District Office |
Other documents for LFB USA, Inc.
- FDA Inspection 1244007 - 2024-06-28
- FDA Inspection 1039570 - 2017-08-22
- FDA Inspection 1028254 - 2017-05-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.